Veradigm provides update on its financial restatement process

Chicago--(business wire)-- #healthit--veradigm inc. (nasdaq: mdrx) (the “company”), a leading provider of healthcare data and technology products and solutions, announced today that the company does not expect to have filed its annual report on form 10-k for the year ended december 31, 2022, or its quarterly reports on form 10-q for the quarters ended march 31, 2023, june 30, 2023 and september 30, 2023, by february 27, 2024, the deadline that the nasdaq stock market llc (“nasdaq”) has given the company to.
MDRX Ratings Summary
MDRX Quant Ranking